See also this year's filing and all EDGAR filings for this company.
PDF Report 0000919722_2013_Astex_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000919722, Astex Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 146,507,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 121,304,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,749,000 |
| 3 | remainder_Assets | 1,604,000 |
| 4 | LiabilitiesCurrent | 19,640,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 18,582,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,662,000 |
| 9 | ResearchAndDevelopmentExpense | 60,418,000 |
| 10 | remainder_Expenses | 1,623,000 |
| 11 | remainder_Revenues | 83,159,000 |
| 12 | remainder_NetIncome | 2,791,000 |
| 13 | remainder_ComprehensiveNetIncome | 4,895,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 275,164,000 |
| 1 | Liabilities | 38,222,000 |
| 2 | Expenses | 77,703,000 |
| 3 | Revenues | 83,159,000 |
| 4 | StockholdersEquity | 236,942,000 |
| 5 | NetIncome | 8,247,000 |
| 6 | ComprehensiveNetIncome | 10,694,500 |
| 7 | BaseVar | 240,967,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.36 |
| 9 | EconomicCapitalRatio | 3.93 |
Edgar->Model Mapping
Feature Distribution
Change over Time
